VYGR — Voyager Therapeutics Share News
0.000.00%
Last trade - 00:00- $107.22m
- -$9.12m
- $40.37m
Voyager Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Voyager Therapeutics Q2 collaboration revenue falls, net loss narrows
Brief: Voyager Therapeutics Q2 Net Income USD -24.473 Million
Voyager Therapeutics Inc expected to post a loss of 48 cents a share - Earnings Preview
Biogen's Alzheimer's drug lowers toxic protein, but results were mixed
Voyager Therapeutics Q1 revenue declines, net loss narrows; first patient dosing set for H2 2026
Brief: Voyager Therapeutics Q1 Collaboration Revenue USD 2.593 Million
Brief: Voyager Therapeutics Inc - Nathan Jorgensen Resigns As CFO Effective May 8, 2026
Voyager Therapeutics Q4 net loss narrows
Biotech firm Voyager's Q3 collaboration revenue drops, net loss widens
Brief: Voyager Therapeutics Q3 Collaboration Revenue USD 13.365 Million
Voyager Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Voyager Therapeutics Q2 EPS USD -0.57
Voyager Therapeutics Inc expected to post a loss of 53 cents a share - Earnings Preview
Refile: Space and defense tech firm Voyager raises $382.8 million in US IPO
U.S. RESEARCH ROUNDUP-Datadog, Masimo, Waters
Voyager Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Voyager Therapeutics Inc expected to post a loss of 37 cents a share - Earnings Preview
Voyager Therapeutics Inc expected to post a loss of 37 cents a share - Earnings Preview